| __timestamp | ADMA Biologics, Inc. | MiMedx Group, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4823869 | 90480000 |
| Thursday, January 1, 2015 | 6745968 | 133384000 |
| Friday, January 1, 2016 | 8494742 | 179997000 |
| Sunday, January 1, 2017 | 18092835 | 220119000 |
| Monday, January 1, 2018 | 22502922 | 258528000 |
| Tuesday, January 1, 2019 | 25910757 | 198205000 |
| Wednesday, January 1, 2020 | 35050817 | 181022000 |
| Friday, January 1, 2021 | 42896889 | 198359000 |
| Saturday, January 1, 2022 | 52458024 | 208789000 |
| Sunday, January 1, 2023 | 59020000 | 211124000 |
Igniting the spark of knowledge
In the ever-evolving landscape of biotechnology, operational efficiency is paramount. Over the past decade, ADMA Biologics, Inc. and MiMedx Group, Inc. have showcased contrasting trajectories in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, MiMedx Group's SG&A expenses surged by approximately 133%, peaking at over 211 million in 2023. In contrast, ADMA Biologics experienced a more dramatic increase of nearly 1,125%, reaching around 59 million in the same year.
Understanding these patterns offers valuable insights into the financial strategies and market positioning of these biotech firms.
Selling, General, and Administrative Costs: Vertex Pharmaceuticals Incorporated vs ADMA Biologics, Inc.
Cost Management Insights: SG&A Expenses for Madrigal Pharmaceuticals, Inc. and MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing Opthea Limited and MiMedx Group, Inc.
ADMA Biologics, Inc. and Amicus Therapeutics, Inc.: SG&A Spending Patterns Compared
Selling, General, and Administrative Costs: ADMA Biologics, Inc. vs HUTCHMED (China) Limited
Comparing SG&A Expenses: ADMA Biologics, Inc. vs Celldex Therapeutics, Inc. Trends and Insights
Breaking Down SG&A Expenses: Ultragenyx Pharmaceutical Inc. vs MiMedx Group, Inc.
Operational Costs Compared: SG&A Analysis of ACADIA Pharmaceuticals Inc. and MiMedx Group, Inc.
Who Optimizes SG&A Costs Better? Bausch Health Companies Inc. or MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing HUTCHMED (China) Limited and MiMedx Group, Inc.
SG&A Efficiency Analysis: Comparing ImmunityBio, Inc. and MiMedx Group, Inc.
Comparing SG&A Expenses: Soleno Therapeutics, Inc. vs MiMedx Group, Inc. Trends and Insights